IntegenX / GenVault Corp

GenVault is dedicated to stabilizing biosamples and to the integration of biosample transport, storage and retrieval, in a way that meshes seamlessly with day-to-day lab operations: thus simplifying sample sharing for customers in genomic medicine, discovery and identification. Today, we are empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies, to more fully leverage the rapidly growing genomics industry. GenVault’s proprietary dry-state storage platform enables the extraction, preservation, recovery and distribution of DNA at ambient temperature. Currently work is proceeding on equivalent storage technologies for protein and RNA.

IntegenX designs, manufactures and markets automation systems enabling reliable microsample preparation and analysis for the life sciences. Sample preparation processes can be complex and expensive, and researchers must choose between cumbersome and error-prone manual procedures and expensive robotic systems. There is also a fundamental mismatch between actual sample volumes and the volumes used by modern analytical instrumentation. This mismatch wastes large amounts of expensive consumables and precious samples. Our proprietary and patented technologies scale large sample volumes to efficient nanoscale solutions that will ultimately reduce labor costs, increase reliability and provide major savings in highly expensive reagents and scarce samples.

IntegenX technologies are aimed at simplifying sample preparation, addressing the issue of volume scale and ultimately developing complete small-footprint ’sample-to-answer’ solutions.